Home
Inbox
Search
Speaker
Eric Speir. Bradford
MD
GlaxoSmithKline;GSK
Bookmark
Session(s)
Durability of Clinical Response Following Long-Term Treatment with Mepolizumab in Patients...
Sunday, May 20
11:15 AM - 1:00 PM
Effect of Mepolizumab (100 mg Subcutaneous) on Exacerbation Rate in Patients with Severe E...
Sunday, May 20
11:15 AM - 1:00 PM
Long-Term Safety of Mepolizumab in Patients with Severe Eosinophilic Asthma: The COLUMBA S...
Sunday, May 20
11:15 AM - 1:00 PM
Pharmacodynamic and Clinical Efficacy Data from Patient Sputum Subgroups in DREAM Treated ...
Sunday, May 20
11:15 AM - 1:00 PM
Eosinophilic Granulomatosis with Polyangiitis Patient Characteristics and Clinical Respons...
Monday, May 21
11:15 AM - 1:00 PM
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis...
Monday, May 21
2:15 PM - 4:15 PM
Fractional Exhaled Nitric Oxide and the Peripheral Blood Eosinophil Count as Biomarkers of...
Tuesday, May 22
2:15 PM - 4:15 PM
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis...
Tuesday, May 22
3:30 PM - 3:45 PM
Home
Inbox
Search